GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » Price-to-Free-Cash-Flow

Synthetic MR AB (XSAT:SYNT) Price-to-Free-Cash-Flow : N/A (As of May. 24, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB Price-to-Free-Cash-Flow?

As of today (2024-05-24), Synthetic MR AB's share price is kr28.10. Synthetic MR AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.41. Hence, Synthetic MR AB's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Synthetic MR AB's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 12 years, Synthetic MR AB's highest Price-to-Free-Cash-Flow Ratio was 64000.00. The lowest was 49.21. And the median was 125.47.

XSAT:SYNT's Price-to-Free-Cash-Flow is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 17.11
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Synthetic MR AB's Free Cash Flow per Share for the three months ended in Mar. 2024 was kr-0.12. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was kr-0.41.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -3.70% per year.

During the past 12 years, Synthetic MR AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 98.30% per year. The lowest was -138.10% per year. And the median was -3.70% per year.


Synthetic MR AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for Synthetic MR AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB Price-to-Free-Cash-Flow Chart

Synthetic MR AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98.67 - - - -

Synthetic MR AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Synthetic MR AB's Price-to-Free-Cash-Flow

For the Health Information Services subindustry, Synthetic MR AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's Price-to-Free-Cash-Flow falls into.



Synthetic MR AB Price-to-Free-Cash-Flow Calculation

Synthetic MR AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=28.10/-0.41
=N/A

Synthetic MR AB's Share Price of today is kr28.10.
Synthetic MR AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.41.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Synthetic MR AB  (XSAT:SYNT) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Synthetic MR AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Syntel enters definitive agreement to be acquired by Atos S.E.

By GlobeNewswire GlobeNewswire 07-22-2018

Gurus Find Hot Information Technology Stocks

By James Li James Li 06-10-2016

Syntel Inc. Reports Operating Results (10-K)

By gurufocus 10qk 03-03-2011

Syntel Joins Google Cloud Partner Program

By Marketwired Marketwired 03-26-2018

Syntel Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-08-2010

RM LAW Announces Investigation of Syntel, Inc.

By PRNewswire PRNewswire 07-26-2018

Syntel Named a Partner of the Year by Pivotal

By Marketwired Marketwired 09-25-2018

Syntel enters definitive agreement to be acquired by Atos S.E.

By Marketwired Marketwired 07-22-2018